Skip to content
Home » An Optimized Tradition Medium for Induced Pluripotent Stem Cells

An Optimized Tradition Medium for Induced Pluripotent Stem Cells


In 2006, Kazutoshi Takahashi and Shinya Yamanaka made a revolutionary breakthrough after they reprogrammed terminally differentiated, lineage-restricted grownup somatic cells right into a pluripotent state by way of the expression of transcription components Oct4, Sox2, Klf4, and c-Myc.1 Now, researchers can differentiate reprogrammed induced pluripotent stem cells (iPSCs) into any cell sort and use them for quite a few functions, together with illness analysis, drug improvement, and personalised regenerative stem cell remedy.2

Rising iPSCs in vitro requires a tradition medium, development components, and an extracellular matrix. The tradition medium high quality profoundly impacts cell development, viability, and differentiated cell sort. Stem cell researchers need secure and constant tradition media to help the long-term enlargement of iPSCs and to realize giant cell portions for downstream differentiation protocols.    

Researchers usually tradition iPSCs in medium containing animal-derived serum and development components. Nonetheless, serum composition and efficiency are variable, which impacts cell tradition high quality resulting in smaller colony sizes, extreme differentiation, and adjustments in cell adhesion properties. Additional, contaminating animal pathogens are a menace to cells destined for therapeutic use. Along with enhancing consistency and security, eradicating serum and different undefined animal parts, resembling development components, from the tradition medium may simplify purification and downstream processing. Combining purified development components and essential serum parts engineered in bacterial programs with an artificial iPSC tradition medium is the widespread trick producers use to exchange animal parts.2      

One other important however doubtlessly problematic element of iPSC cultures are feeder cells, which offer a floor for iPSCs to develop. Murine fibroblasts are generally used as feeder cells, however they’ll introduce animal pathogens into cultures. Furthermore, feeder cells usually secrete proteins that trigger progenitor cells to proliferate and differentiate. iPSCs should preserve their pluripotency, and spontaneous differentiation is a significant hurdle in establishing secure, long-term pluripotent cultures. To lower security issues and obtain minimal spontaneous differentiation, researchers should irradiate or chemically inactivate feeder cells previous to culturing iPSCs on them. Because of these issues, there may be an incentive for stem cell researchers to undertake serum-free, animal-free tradition media.3,4

ExCellerate™ iPSC Enlargement Medium is a serum- and feeder-free tradition medium devoid of any animal parts, offering a secure and reproducible development atmosphere for iPSCs with out the necessity for extra development components and dietary supplements. The absence of animal parts reduces batch-to-batch variability and provides constant efficiency in development and viability throughout completely different cell strains.

Human iPSC (hiPSC) cell strains of various origins cultured in ExCellerate medium present traits of wholesome cells, resembling densely packed cell colonies which might be clean and spherical. Even after greater than 45 passages, hiPSCs grown on this enlargement medium preserve sturdy expression of Oct4 and Sox2 pluripotency markers. Moreover, hiPSCs show regular karyotypes even after greater than 30 passages, which highlights the genetic stability of those cultures. Lastly, iPSCs maintained on ExCellerate medium can differentiate into quite a few cell sorts, resembling cardiomyocytes, hepatocytes, and neurons, and with improved security profiles, they’re appropriate for medical functions resembling transplantation.


  1. Okay. Takahashi, S. Yamanaka, “Induction of pluripotent stem cells from mouse embryonic and grownup fibroblast cultures by outlined components,” Cell, 126(4):663-76, 2006.
  2. M. Doss, A. Sachinidis, “Present challenges of iPSC-based illness modeling and therapeutic implications,” Cells, 8(5):403, 2019.
  3. S. Llames et al., “Feeder layer cell actions and functions,” Tissue Eng Half B Rev, 21(4):345-53, 2015.
  4. S. Salt, “Expertise Digest: the significance of serum- and animal component-free media for stem cell-based therapeutics,”, accessed on November 18, 2021.


Supply hyperlink